Sarepta Therapeutics, Inc.: H-1B filings and workplace records, Cambridge, Massachusetts
Sarepta Therapeutics, Inc. filed 13 labor condition applications (LCA) in fiscal year 2026, to 30 June 2026. OFLC certified all of them. The median offered wage on its LCAs in fiscal years 2025 to 2026 is $123,500 a year. It filed 3 PERM applications in fiscal year 2026, to 30 June 2026. OFLC certified all of them. An LCA is a filing. It is not a visa and it is not a job.
Is this the same company?
The site joins the records of each agency by employer name and by state. It has no other key.
A record on this page can belong to a different firm that has the same name.
Since the last update
No change. The site tracks the LCA filings, PERM applications, OSHA inspections and back wages of this employer record. Changes and data dates
H-1B and PERM: Office of Foreign Labor Certification
Decisions to Newest file fiscal year 2026, quarter 3Read from the committed copy
Employer-specific case information that appears on this website was provided to OFLC by employers who submitted prevailing wage, labor certification and labor attestation applications for processing. These are not employer responses to the Bureau of Labor Statistics' Occupational Employment Statistics (BLS-OES) survey.
Any typographical errors or other data anomalies (e.g., incomplete or blank data fields, etc.) may be due to internal data entry or other external customer errors in completing and submitting the applications for processing.
A small percentage of determinations may be subject to change in subsequent quarterly releases due to appeal or redetermination decisions on employer applications.
The words of the Office of Foreign Labor Certification. Source: Performance Data, read .
- LCA filings, fiscal year 2026
- 13100% certified, year to date
- Median offered wage
- $123,500a year; prevailing $104,905
- Worker positions
- 40fiscal years 2025 to 2026
- PERM applications, fiscal year 2026
- 3100% certified
| Fiscal year | Filings | Certified | Certified share | Denied | Withdrawn |
|---|---|---|---|---|---|
| 2025 | 27 | 27 | 100% | 0 | 0 |
| 2026 | 13 | 13 | 100% | 0 | 0 |
| Job title | Median offered wage | LCA filings |
|---|---|---|
| Senior Engineer, Gene Therapy Upstream Process Development | $104,416 | 3 |
| Scientist II, Discovery Chemistry | No data | 2 |
| Associate Director, Statistical Programming | No data | 2 |
| Senior Manager, Social Media Engagement | No data | 2 |
| Principal Engineer, Manufacturing Sciences and Technology | No data | 1 |
| Engineer, RNA Drug Substance Manufacturing | No data | 1 |
| Executive Dir., Gene Therapy Commercialization Capabilities | No data | 1 |
| Quality Control Associate II “ Physical Titer | No data | 1 |
| Senior Engineer, QA Validation and Engineering | No data | 1 |
| Senior Research Associate | No data | 1 |
| Data Analytics Lead Engineer | No data | 1 |
| Quality Control Associate II, Potency | No data | 1 |
A wage is a year: the rate on the form times its unit, so an hourly rate times 2,080. A median needs three or more applications that state a wage. The list holds the twelve most frequent job titles.
Prevailing wage levels on the filings
| Level | Filings | Share |
|---|---|---|
| Level I | 6 | 15% |
| Level II | 15 | 38% |
| Level III | 10 | 25% |
| Level IV | 9 | 23% |
| Not stated | 0 | 0% |
| Occupation (SOC) | LCA filings | Median offered wage, all employers |
|---|---|---|
| Medical Scientists, Except Epidemiologists | 19 | $75,000 |
| Validation Engineers | 3 | $108,000 |
| Marketing Managers | 3 | $175,000 |
| Bioinformatics Scientists | 3 | $82,100 |
| Biological Technicians | 2 | $57,108 |
| Industrial Production Managers | 2 | $140,181 |
| Data Scientists | 1 | $123,741 |
| Computer Systems Analysts | 1 | $106,553 |
| Worksite state | LCA filings |
|---|---|
| Massachusetts | 36 |
| North Carolina | 2 |
| Texas | 1 |
| Ohio | 1 |
OFLC files an LCA under the state of the employer address on the form (Massachusetts). The worksites can be in other states.
PERM applications (permanent labor certification)
| Fiscal year | Applications | Certified | Denied | Withdrawn |
|---|---|---|---|---|
| 2024 | 0 | 0 | 0 | 0 |
| 2025 | 3 | 3 | 0 | 0 |
| 2026 | 3 | 3 | 0 | 0 |
| Job title | Applications |
|---|---|
| Lead Engineer QA IT Validation | 1 |
| Data Analytics Principal Engineer | 1 |
| Executive Director | 1 |
| Principal Statistical Programmer | 1 |
| Senior Engineer, Gene Therapy Upstream Process Development | 1 |
| Bioinformatics Scientist II | 1 |
| Occupation (SOC) | Applications |
|---|---|
| Molecular and Cellular Biologists | 3 |
| Software Quality Assurance Analysts and Testers | 1 |
| Marketing Managers | 1 |
| Statisticians | 1 |
Fiscal year 2024 holds the applications on the new Form 9089 only. The median offered wage on the PERM applications is $128,011 a year.
Injury summaries: OSHA Injury Tracking Application, Form 300A
Calendar years 2023 to 2025Read from the committed copy
While OSHA takes multiple steps to ensure the data collected are accurate, problems and errors invariably exist for some establishments. Efforts are made during the collection cycle to correct submission errors; however, some remain unresolved. OSHA does not validate the employee or injury and illness counts reported by establishments.
Recording or reporting a work-related injury, illness, or fatality does not mean that the employer or employee was at fault, that an OSHA rule has been violated, or that the employee is eligible for workers' compensation or other benefits.
The words of the Occupational Safety and Health Administration. Source: Injury Tracking Application (ITA) Data, read .
- Total recordable case rate, 2025
- 0.0cases for each 100 full-time workers
- Days away, restricted or transferred (DART), 2025
- 0.0
- Employees reported, 2025
- 6921 establishment
- Recordable cases, 2025
- 00 deaths
| Group | Total recordable case rate |
|---|---|
| This record | 0.0 |
| Median establishment, NAICS 325 | 0.9 |
| All establishments, NAICS 325 | 1.4 |
| All establishments, Massachusetts | 3.5 |
| All establishments, United States | 3.5 |
| Year | Establishments | Employees | Hours worked | Deaths | Days away | Restricted or transferred | Other cases | Case rate | DART rate |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | 1 | 692 | 1,439,360 | 0 | 0 | 0 | 0 | 0.0 | 0.0 |
The figures add up every establishment that filed under this name in Massachusetts. A rate is blank when the establishments reported fewer than 2,000 hours. The median establishment has 20,000 hours or more.
No record at these agencies
OSHA inspections
The enforcement data since 2016 has no OSHA inspection of this employer in Massachusetts. OSHA records an inspection at the establishment, so sites in other states are under those states.
Records to . Inspections opened since 2016. Read from the agency.
Back wages
The data since fiscal year 2005 has no concluded Wage and Hour Division case of this employer in Massachusetts.
Concluded cases to . Cases since fiscal year 2005. Read from the agency.
Federal contracts
This employer is not among the 3,903 largest federal contract recipients of the latest 12 months that the site loads from USAspending.
Period the latest 12 months. Read from the agency.
Union elections
The site holds no NLRB election results at this time. nlrb.gov did not accept the requests of the site, so the copy is empty.
Data none, the copy on this site is empty. Not read from the agency.
Other employers in Massachusetts
These links help you move through the records. The list is in name order. It is not a ranking.
Chemical Manufacturing in Massachusetts
- Agios Pharmaceuticals, Inc.Cambridge
- Akebia Therapeutics, Inc.Cambridge
- Alnylam US, Inc.Cambridge
- Biogen Inc.Cambridge
- Bioverativ Therapeutics, Inc.Cambridge
- City Therapeutics, Inc.Cambridge
- Genzyme Therapeutic Products Limited PartnershipCambridge
- Takeda Development Center Americas, Inc.Cambridge
- Takeda Manufacturing USA Inc.Cambridge
- Takeda Pharmaceuticals America Inc.Cambridge
- Takeda Pharmaceuticals USA, Inc.Cambridge
- Takeda Vaccines Inc.Cambridge
Questions about this record
- What happened to the LCAs of Sarepta Therapeutics, Inc.?
- Sarepta Therapeutics, Inc. filed 40 LCAs in fiscal years 2025 to 2026. OFLC certified all of them. OFLC denied none. The employer withdrew none.
- Which job title is most frequent on the LCAs of Sarepta Therapeutics, Inc.?
- The job title Senior Engineer, Gene Therapy Upstream Process Development has 3 filings. Its median offered wage is $104,416 a year.
- Which prevailing wage levels do the LCAs state?
- The LCAs state Level I in 15%, Level II in 38%, Level III in 25% and Level IV in 23%. The employer states the level on the form.
- Has OSHA inspected Sarepta Therapeutics, Inc. in Massachusetts?
- The enforcement data since 2016 has no OSHA inspection of this employer in Massachusetts. Sites in other states have their own records.
Official channels
- OSHAOSHA establishment searchOccupational Safety and Health Administration. Address checked .
- 300AOSHA injury and illness data (Form 300A)Occupational Safety and Health Administration. Address checked .
- OFLCOFLC performance data (LCA and PERM disclosure files)Office of Foreign Labor Certification. Address checked .
- WHDHow to file a complaint with the Wage and Hour DivisionWage and Hour Division. Address checked .
Cite this page
Employer Ledger. "Sarepta Therapeutics, Inc. (Massachusetts)." https://employerledger.com/employer/sarepta-therapeutics-inc-ma/. Records of: Office of Foreign Labor Certification; OSHA Injury Tracking Application, Form 300A. Newest record .
The address of this page does not change. The figures change when an agency publishes new records.
Where the figures come from
- OFLC Office of Foreign Labor Certification. Decisions to . Newest file fiscal year 2026, quarter 3. Read , from the committed copy.
- OSHA Occupational Safety and Health Administration. Records to . Inspections opened since 2016. Read , from the agency.
- 300A OSHA Injury Tracking Application, Form 300A. Calendar years 2023 to 2025. Read , from the committed copy.
- WHD Wage and Hour Division. Concluded cases to . Cases since fiscal year 2005. Read , from the agency.
- USAspending USAspending.gov. Period the latest 12 months. Read , from the agency.
The site built this page on . The methodology tells how records are matched and counted. To report an error in the processing, use the corrections page. The agency that holds a record decides disputes about it.